BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tsukamoto T, Yokoi T, Maruta S, Kitamura M, Yamamoto T, Ban H, Tatematsu M. Gastric adenocarcinoma with chief cell differentiation. Pathol Int. 2007;57:517-522. [PMID: 17610477 DOI: 10.1111/j.1440-1827.2007.02134.x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 2.9] [Reference Citation Analysis]
Number Citing Articles
1 Jukić Z, Bacalja J, Kristek J, Bekavac-Bešlin M, Krušlin B. Extremely Well-Differentiated Gastric Adenocarcinoma Arising in Pylorus with Minor Diffuse Adenocarcinoma Component. J Gastrointest Cancer 2018;49:75-7. [PMID: 27377388 DOI: 10.1007/s12029-016-9851-3] [Reference Citation Analysis]
2 Rendón-Huerta E, Teresa F, Teresa GM, Xochitl GS, Georgina AF, Veronica ZZ, Montaño LF. Distribution and expression pattern of claudins 6, 7, and 9 in diffuse- and intestinal-type gastric adenocarcinomas. J Gastrointest Cancer 2010;41:52-9. [PMID: 19960275 DOI: 10.1007/s12029-009-9110-y] [Cited by in F6Publishing: 25] [Reference Citation Analysis]
3 Lee TI, Jang JY, Kim S, Kim JW, Chang YW, Kim YW. Oxyntic gland adenoma endoscopically mimicking a gastric neuroendocrine tumor: A case report. World J Gastroenterol 2015; 21(16): 5099-5104 [PMID: 25945027 DOI: 10.3748/wjg.v21.i16.5099] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
4 Fan X, Yang XS, Bai P, Ren YB, Zhang L, Li X, Wang L, Wang Y, Ding YM, Zeng RR, Lin XC. Gastric adenocarcinoma of the fundic gland type: A case report. Medicine (Baltimore) 2020;99:e20361. [PMID: 32481329 DOI: 10.1097/MD.0000000000020361] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Pereira D, Kővári B, Brown I, Chaves P, Choi WT, Clauditz T, Ghayouri M, Jiang K, Miller GC, Nakanishi Y, Kim KM, Kim BH, Kumarasinghe MP, Kushima R, Ushiku T, Yozu M, Srivastava A, Goldblum JR, Pai RK, Lauwers GY. Non-conventional dysplasias of the tubular gut: a review and illustration of their histomorphological spectrum. Histopathology 2021;78:658-75. [PMID: 33124049 DOI: 10.1111/his.14294] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Sato Y, Sato T, Matsushima J, Fujii A, Ono Y, Suda T, Katayama Y, Ban S. Histopathologic Change of a Case of Gastric Oxyntic Neoplasm (Gastric Adenocarcinoma of Fundic Gland Mucosa Type) Through 5 Years With Concurrent Other Oxyntic Gland Lesions. Int J Surg Pathol 2021;29:557-64. [PMID: 33030084 DOI: 10.1177/1066896920962574] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Zhou C, Chen G, Jiang JG. Gastric oxyntic gland neoplasm: A case series. Asian J Surg 2021:S1015-9584(21)00654-0. [PMID: 34815147 DOI: 10.1016/j.asjsur.2021.10.014] [Reference Citation Analysis]
8 Lennerz JK, Kim SH, Oates EL, Huh WJ, Doherty JM, Tian X, Bredemeyer AJ, Goldenring JR, Lauwers GY, Shin YK. The transcription factor MIST1 is a novel human gastric chief cell marker whose expression is lost in metaplasia, dysplasia, and carcinoma. Am J Pathol. 2010;177:1514-1533. [PMID: 20709804 DOI: 10.2353/ajpath.2010.100328] [Cited by in Crossref: 78] [Cited by in F6Publishing: 78] [Article Influence: 6.5] [Reference Citation Analysis]
9 Kakumoto A, Kuroda H, Jamiyan T, Shimakawa T, Masunaga A. Gastric Adenocarcinoma of the Fundic Gland Type: A Case Report. Am J Case Rep 2021;22:e933474. [PMID: 34853292 DOI: 10.12659/AJCR.933474] [Reference Citation Analysis]
10 Ueyama H, Yao T, Nakashima Y, Hirakawa K, Oshiro Y, Hirahashi M, Iwashita A, Watanabe S. Gastric adenocarcinoma of fundic gland type (chief cell predominant type): proposal for a new entity of gastric adenocarcinoma. Am J Surg Pathol. 2010;34:609-619. [PMID: 20410811 DOI: 10.1097/pas.0b013e3181d94d53] [Cited by in Crossref: 95] [Cited by in F6Publishing: 46] [Article Influence: 7.9] [Reference Citation Analysis]
11 Fukatsu H, Miyoshi H, Ishiki K, Tamura M, Yao T. Gastric adenocarcinoma of fundic gland type (chief cell predominant type) treated with endoscopic aspiration mucosectomy. Dig Endosc. 2011;23:244-246. [PMID: 21699569 DOI: 10.1111/j.1443-1661.2011.01125.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
12 Nomura R, Saito T, Mitomi H, Hidaka Y, Lee SY, Watanabe S, Yao T. GNAS mutation as an alternative mechanism of activation of the Wnt/β-catenin signaling pathway in gastric adenocarcinoma of the fundic gland type. Hum Pathol. 2014;45:2488-2496. [PMID: 25288233 DOI: 10.1016/j.humpath.2014.08.016] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 4.0] [Reference Citation Analysis]
13 Park ES, Kim YE, Park CK, Yao T, Kushima R, Kim KM. Gastric adenocarcinoma of fundic gland type: report of three cases. Korean J Pathol. 2012;46:287-291. [PMID: 23110017 DOI: 10.4132/koreanjpathol.2012.46.3.287] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
14 Kai K, Satake M, Tokunaga O. Gastric adenocarcinoma of fundic gland type with signet-ring cell carcinoma component: A case report and review of the literature. World J Gastroenterol 2018; 24(26): 2915-2920 [PMID: 30018486 DOI: 10.3748/wjg.v24.i26.2915] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
15 Ushiku T, Kunita A, Kuroda R, Shinozaki-Ushiku A, Yamazawa S, Tsuji Y, Fujishiro M, Fukayama M. Oxyntic gland neoplasm of the stomach: expanding the spectrum and proposal of terminology. Mod Pathol 2020;33:206-16. [PMID: 31375767 DOI: 10.1038/s41379-019-0338-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
16 Sato Y, Fujino T, Kasagawa A, Morita R, Ozawa SI, Matsuo Y, Maehata T, Yasuda H, Takagi M, Itoh F. Twelve-year natural history of a gastric adenocarcinoma of fundic gland type. Clin J Gastroenterol. 2016;9:345-351. [PMID: 27624750 DOI: 10.1007/s12328-016-0680-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
17 Chan K, Brown IS, Kyle T, Lauwers GY, Kumarasinghe MP. Chief cell-predominant gastric polyps: a series of 12 cases with literature review. Histopathology. 2016;68:825-833. [PMID: 26335020 DOI: 10.1111/his.12859] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 2.7] [Reference Citation Analysis]
18 Singhi AD, Lazenby AJ, Montgomery EA. Gastric adenocarcinoma with chief cell differentiation: a proposal for reclassification as oxyntic gland polyp/adenoma. Am J Surg Pathol. 2012;36:1030-1035. [PMID: 22472957 DOI: 10.1097/pas.0b013e31825033e7] [Cited by in Crossref: 52] [Cited by in F6Publishing: 18] [Article Influence: 5.2] [Reference Citation Analysis]
19 Murakami T, Mitomi H, Yao T, Saito T, Shibuya T, Watanabe S. Epigenetic regulation of Wnt/β-catenin signal-associated genes in gastric neoplasia of the fundic gland (chief cell-predominant) type. Pathol Int 2017;67:147-55. [PMID: 28105693 DOI: 10.1111/pin.12509] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
20 Iwamuro M, Kusumoto C, Nakagawa M, Kobayashi S, Yoshioka M, Inaba T, Toyokawa T, Hori S, Tanaka S, Matsueda K, Tanaka T, Okada H. Endoscopic resection is a suitable initial treatment strategy for oxyntic gland adenoma or gastric adenocarcinoma of the fundic gland type. Sci Rep 2021;11:7375. [PMID: 33795810 DOI: 10.1038/s41598-021-86893-w] [Reference Citation Analysis]
21 Miyazawa M, Matsuda M, Yano M, Hara Y, Arihara F, Horita Y, Matsuda K, Sakai A, Noda Y. Gastric adenocarcinoma of the fundic gland (chief cell-predominant type): A review of endoscopic and clinicopathological features. World J Gastroenterol 2016; 22(48): 10523-10531 [PMID: 28082804 DOI: 10.3748/wjg.v22.i48.10523] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
22 Chiba T, Kato K, Masuda T, Ohara S, Iwama N, Shimada T, Shibuya D. Clinicopathological features of gastric adenocarcinoma of the fundic gland (chief cell predominant type) by retrospective and prospective analyses of endoscopic findings. Dig Endosc. 2016;28:722-730. [PMID: 27129734 DOI: 10.1111/den.12676] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
23 Ueo T, Yonemasu H, Ishida T. Gastric adenocarcinoma of fundic gland type with unusual behavior. Dig Endosc. 2014;26:293-294. [PMID: 24321002 DOI: 10.1111/den.12212] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.2] [Reference Citation Analysis]
24 Yamada S, Yamanoi K, Sato Y, Nakayama J. Diffuse MIST1 expression and decreased α1,4-linked N-acetylglucosamine (αGlcNAc) glycosylation on MUC6 are distinct hallmarks for gastric neoplasms showing oxyntic gland differentiation. Histopathology 2020;77:413-22. [PMID: 32502322 DOI: 10.1111/his.14165] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
25 Jeong YS, Kim SE, Kwon MJ, Seo JY, Lim H, Park JW, Kang HS, Moon SH, Kim JH, Park CK. Signet-ring cell carcinoma arising from a fundic gland polyp in the stomach. World J Gastroenterol 2014; 20(47): 18044-18047 [PMID: 25548505 DOI: 10.3748/wjg.v20.i47.18044] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
26 Hidaka Y, Mitomi H, Saito T, Takahashi M, Lee SY, Matsumoto K, Yao T, Watanabe S. Alteration in the Wnt/β-catenin signaling pathway in gastric neoplasias of fundic gland (chief cell predominant) type. Hum Pathol. 2013;44:2438-2448. [PMID: 24011952 DOI: 10.1016/j.humpath.2013.06.002] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 3.8] [Reference Citation Analysis]
27 Cha HJ, Kim K, Kim M, Choi H, Kim YM, Suh JH. Concurrent Gastric Adenocarcinoma of Fundic Gland Type and Carcinoma with Lymphoid Stroma: A Rare Case Report. Case Rep Gastroenterol. 2016;10:292-301. [PMID: 27462199 DOI: 10.1159/000444277] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
28 Tohda G, Osawa T, Asada Y, Dochin M, Terahata S. Gastric adenocarcinoma of fundic gland type: Endoscopic and clinicopathological features. World J Gastrointest Endosc 2016; 8(4): 244-251 [PMID: 26962407 DOI: 10.4253/wjge.v8.i4.244] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
29 Chen O, Shao ZY, Qiu X, Zhang GP. Multiple gastric adenocarcinoma of fundic gland type: A case report. World J Clin Cases 2019; 7(18): 2871-2878 [PMID: 31616705 DOI: 10.12998/wjcc.v7.i18.2871] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
30 Hassan MI, Toor A, Ahmad F. Progastriscin: structure, function, and its role in tumor progression. J Mol Cell Biol 2010;2:118-27. [PMID: 20231168 DOI: 10.1093/jmcb/mjq001] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 2.3] [Reference Citation Analysis]
31 Yu YN, Yin XY, Sun Q, Liu H, Zhang Q, Chen YQ, Zhao QX, Tian ZB. Gastric adenocarcinoma of fundic gland type after Helicobacter pylori eradication: A case report. World J Clin Cases 2019; 7(13): 1696-1702 [PMID: 31367629 DOI: 10.12998/wjcc.v7.i13.1696] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
32 Ueyama H, Yao T, Akazawa Y, Hayashi T, Kurahara K, Oshiro Y, Yamada M, Oda I, Fujioka S, Kusumoto C, Fukuda M, Uchita K, Kadota T, Oono Y, Okamoto K, Murakami K, Matsuo Y, Kato M, Maehata T, Yahagi N, Yasuhara Y, Yada T, Uraushihara K, Yamane T, Matsuo T, Ito M, Maruyama Y, Osako A, Ono S, Kato M, Yagi K, Hashimoto T, Tomita N, Tsuyama S, Saito T, Matsumoto K, Matsumoto K, Watanabe S, Uemura N, Chiba T, Nagahara A. Gastric epithelial neoplasm of fundic-gland mucosa lineage: proposal for a new classification in association with gastric adenocarcinoma of fundic-gland type. J Gastroenterol 2021;56:814-28. [PMID: 34268625 DOI: 10.1007/s00535-021-01813-z] [Reference Citation Analysis]
33 Chen WC, Rodriguez-Waitkus PM, Barroso A, Balsaver A, McKechnie JC. A Rare Case of Gastric Fundic Gland Adenocarcinoma (Chief Cell Predominant Type). J Gastrointest Cancer. 2012;43 Suppl 1:S262-S265. [PMID: 22791069 DOI: 10.1007/s12029-012-9416-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
34 Kanesaka T, Uedo N, Yao K, Tanabe H, Yamasaki Y, Takeuchi Y, Iwashita A, Tomita Y. New subtype of gastric adenocarcinoma: mixed fundic and pyloric mucosa-type adenocarcinoma. Clin J Gastroenterol 2017;10:224-8. [DOI: 10.1007/s12328-017-0727-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
35 Li C, Wu X, Yang S, Yang X, Yao J, Zheng H. Gastric adenocarcinoma of the fundic gland type: clinicopathological features of eight patients treated with endoscopic submucosal dissection. Diagn Pathol 2020;15:131. [PMID: 33097069 DOI: 10.1186/s13000-020-01047-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
36 Taniguchi M, Morimoto Y, Miyake Y, Yamanaka C, Ueno G, Miyake T, Fukushima Y, Ejima S, Yutani C. A case of multiple early gastric cancers with variant differentiation including gastric adenocarcinoma of fundic gland type. Pathol Int 2019;69:559-61. [PMID: 31368139 DOI: 10.1111/pin.12843] [Reference Citation Analysis]
37 Meng X, Yang G, Dong C, Zheng R. Gastric adenocarcinoma of the fundic gland: A review of clinicopathological characteristics, treatment and prognosis. Rare Tumors 2021;13:203636132110601. [DOI: 10.1177/20363613211060171] [Reference Citation Analysis]
38 Miyazawa M, Matsuda M, Yano M, Hara Y, Arihara F, Horita Y, Matsuda K, Sakai A, Noda Y. Gastric adenocarcinoma of fundic gland type: Five cases treated with endoscopic resection. World J Gastroenterol 2015; 21(26): 8208-8214 [PMID: 26185396 DOI: 10.3748/wjg.v21.i26.8208] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
39 Liu L, Han L, Ma Q, Zhang J. Gastric adenocarcinoma of fundic gland (chief cell predominant type) coexisting with well differentiated intestinal adenocarcinoma: A case report. Medicine (Baltimore) 2021;100:e25861. [PMID: 34032698 DOI: 10.1097/MD.0000000000025861] [Reference Citation Analysis]
40 Zardawi IM, Munro WS. Oxyntic gland polyposis. Pathology 2015;47:184-6. [DOI: 10.1097/pat.0000000000000218] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
41 Terada T. Well differentiated adenocarcinoma of the stomach composed of chief cell-like cells and parietal cells (Gastric adenocarcinoma of fundic gland type). Int J Clin Exp Pathol. 2011;4:797-798. [PMID: 22135729 DOI: 10.1002/ijc.25536] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
42 Benedict MA, Lauwers GY, Jain D. Gastric Adenocarcinoma of the Fundic Gland Type: Update and Literature Review. Am J Clin Pathol 2018;149:461-73. [PMID: 29648578 DOI: 10.1093/ajcp/aqy019] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 5.5] [Reference Citation Analysis]